Insulin lispro mix 25/75 twice daily (LM25) vs basal insulin glargine once daily and prandial insulin lispro once daily (BP) in type 2 diabetes: insulin intensification

被引：0
|
作者：
Tinahones, F. J. [1 ]
Gross, J. L. [2 ]
Onaca, A.
Zhou, Z. [3 ,4 ]
Cleall, S. [5 ]
Rodriguez, A. [6 ]
机构：
[1] Hosp Univ Virgen de la Victoria, Malaga, Spain
[2] Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil
[3] Second Xiangya Hosp, Ctr Diabet, Inst Metab & Endocrinol, Changsha, Hunan, Peoples R China
[4] Key Lab Diabet Immunol, Changsha, Hunan, Peoples R China
[5] Eli Lilly & Co, Windlesham, Surrey, England
[6] Lilly Spain, Alcobendas, Spain
来源：
DIABETOLOGIA | 2013年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1025
引用
收藏
页码：S412 / S412
页数：1
相关论文
共 50 条
  • [31] Therapeutic effectiveness of two insulin regimens for insulin naive patients with type 2 diabetes mellitus: Once-daily basal insulin or twice-daily premixed insulin?
    Sun, Peter
    Wang, Ruoping
    Jacober, Scott J.
    DIABETES, 2006, 55 : A101 - A101
  • [32] Prandial insulin substitution with insulin lispro or insulin lispro, mid mixture vs. basal therapy with insulin glargine:: A randomized controlled trial in patients with type 2 diabetes beginning insulin therapy
    Kazda, C
    Hülstrunk, H
    Helsberg, K
    Langer, F
    Forst, T
    Hanefeld, M
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2006, 20 (03) : 145 - 152
  • [33] Prandial inhaled insulin plus basal insulin glargine versus twice daily biaspart insulin for type 2 diabetes: a multicentre randomised trial
    Rosenstock, Julio
    Lorber, Daniel L.
    Gnudi, Luigi
    Howard, Campbell P.
    Bilheimer, David W.
    Chang, P-C
    Petrucci, Richard E.
    Boss, Anders H.
    Richardson, Peter C.
    LANCET, 2010, 375 (9733): : 2244 - 2253
  • [34] Initiation and Intensification with 75% Insulin Lispro Protamine Suspension, 25% Insulin Lispro (LM75/25) Is Noninferior to Glargine Plus Lispro (G plus L) in Patients with Type 2 Diabetes (T2D): Results of the PARADIGM Study
    Oliveira, Juliana H.
    Felicio, Joao S.
    Ji, Linong
    Landry, John
    Reed, Victoria A.
    Bowering, Keith C.
    DIABETES, 2010, 59 : A171 - A172
  • [35] Detemir as a once-daily basal insulin in type 2 diabetes
    Nelson, Scott E.
    CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2011, 3 : 27 - 37
  • [36] DURAbility of Basal Versus Lispro Mix 75/25 Insulin Efficacy (DURABLE) Trial 24-Week Results Safety and efficacy of insulin lispro mix 75/25 versus insulin glargine added to oral antihyperglycemic drugs in patients with type 2 diabetes
    Buse, John B.
    Woleeenbuttel, Bruce H. R.
    Herman, William H.
    Shemonsky, Natalie K.
    Jiang, Honghua H.
    Fahrbach, Jessie L.
    Scism-Bacon, Jamie L.
    Martin, Sherry A.
    DIABETES CARE, 2009, 32 (06) : 1007 - 1013
  • [37] Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial (vol 371, pg 1073, 2008)
    Bretzel, R. G.
    Nuber, U.
    Landgraf, W.
    Owens, D. R.
    Bradley, C.
    Linn, T.
    LANCET, 2008, 372 (9640): : 718 - 718
  • [38] Efficacy and Safety of Prandial Premixed Therapy Using Insulin Lispro Mix 50/50 3 Times Daily Compared With Progressive Titration of Insulin Lispro Mix 75/25 or Biphasic Insulin Aspart 70/30 Twice Daily in Patients With Type 2 Diabetes Mellitus: A Randomized, 16-Week, Open-Label Study
    Farcasiu, Eugenia
    Ivanyi, Tibor
    Mozejko-Pastewka, Barbara
    Birkus, Zita
    Csog, Jozsef
    Kowalska, Irina
    Coetzer, Thomas Frederic
    Bulgurlu, Sami
    Schinzel, Birgit
    Kiljanski, Jacek
    CLINICAL THERAPEUTICS, 2011, 33 (11) : 1682 - 1693
  • [39] Durability of glycaemic control with insulin lispro mix 25 vs glargine for older patients with type 2 diabetes
    Jovanovic, L.
    Peters, A.
    Jiang, H.
    Hardin, D.
    DIABETOLOGIA, 2011, 54 : S428 - S428
  • [40] The cost-effectiveness of exenatide twice daily (BID) vs insulin lispro three times daily (TID) as add-on therapy to titrated insulin glargine in patients with type 2 diabetes
    Gordon, J.
    McEwan, P.
    Sabale, U.
    Kartman, B.
    Wolffenbuttel, B. H. R.
    JOURNAL OF MEDICAL ECONOMICS, 2016, 19 (12) : 1167 - 1174
12345